Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01081
Species: Homo sapiens
Position : chr4:15581130-15619993
Year: 2020
Title: H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  32242051
MONDO:
Tissue: Embryonic Kidney
Tissue Ontology ID: UBERON:0002113
Cell Source: HEK293
CVCL ID: CVCL_0045
Cell Type: embryonic kidney cell
Cell Ontology ID: CL:0002139
Experiment Type: Enhancer activity assay, Chromatin interaction assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, ATAC-seq, 3C-seq (Capture-C), RNA-seq
Low Throughput Method: ChIP-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene : TAPT1
About TF
TF name : MLL-AF4
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_00721 chr4:15581130-15619993 Bone Marrow B lymphoblast acute lymphoblastic leukemia
E_00722 chr4:15581130-15619993 Colon colorectal carcinoma cell colorectal carcinoma
E_00723 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_01082 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_01083 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_01084 chr4:15581130-15619993 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer